An announcement was made today by the Dermapharm Holding SE’s Supervisory Board that they have slightly changed the composition of the Management Board. The existing Chief Marketing Officer Stefan Grieving will be leaving the firm for health reasons on 31st July 2019. Doctor Jürgen Ott to succeed him as of 1st October 2019.
Chairman of the Supervisory Board of Dermapharm Holding SE, Wilhelm Beier passed a statement which said they would like to thank Mister Grieving for his long-lasting commitment to Dermapharm. Over the last 9 years, he has played a vital role in shaping our firm’s positive development, & we have come to value him as a proficient & loyal colleague. Wishing him all the luck for the future! In Doctor Jürgen Ott, we now have found a suitable successor as CMO who, due to his broad experience in the consumer goods & pharmaceutical industries, fits perfectly with Dermapharm.
Doctor Jürgen Ott, 51, has plenty of experience in the marketing & sales sectors & will be responsible for both marketing and sales in his function as a member of the Dermapharm Management Board. His last position as from 2010 was Head of Marketing Germany, as from 2014 Head of Marketing & Sales Germany & since 2017 Regional Head Central Europe at Bionorica SE, a maker of herbal pharmaceuticals. Particularly, Doctor Ott brings significant experience to the range of herbal products, which Dermapharm wants to develop in the future.
Doctor Jürgen Ott stated that he was very much looking forward to his tasks at Dermapharm. Together with his colleagues, they will be setting important impulses for the optimal advance development of the range of herbal products as part of their growth strategy & further advance Dermapharm’s position as a leading pharmaceutical manufacturer in selected markets.